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Little is known about cellular determinants essential for human hepatitis B virus infection. Using the duck
hepatitis B virus as a model, we first established a sensitive binding assay for both virions and subviral
particles and subsequently elucidated the characteristics of the early viral entry steps. The infection itinerary
was found to initiate with the attachment of viral particles to a low number of binding sites on hepatocytes
(about 104 per cell). Virus internalization was fully accomplished in less than 3 h but was then followed by a
period of unprecedented length, about 14 h, until completion of nuclear import of the viral genome. Steps
subsequent to virus entry depended on both intact microtubules and their dynamic turnover but not on actin
cytoskeleton. Notably, cytoplasmic trafficking of viral particles and emergence of nuclear covalently closed
circular DNA requires microtubules during entry only at and for specific time periods. Taken together, these
data disclose for the first time a series of steps and their kinetics that are essential for the entry of hepatitis
B viruses into hepatocytes and are different from those of any other virus reported so far.
Infections by animal viruses begin with the attachment of the
viruses to their respective host cells, followed by internaliza-
tion, uncoating, and delivery of the viral genome to its cellular
replication site. These early steps are poorly characterized for
hepadnaviruses, pararetroviruses which almost exclusively in-
fect hepatocytes, leading to both limited and persistent noncy-
totoxic infections (for a review, see reference 6). Studies ad-
dressing the early steps of the hepadnavirus life cycle were
hampered mainly by the lack of permissive cell lines and low
signal intensities. Despite these restrictions, a number of cel-
lular proteins have been proposed to serve as receptors for
human hepatitis B virus (HBV); however, none of these pro-
teins renders infection-resistant cell lines or primary cells sus-
ceptible to HBV infection. Progress in this field has been
greater in the surrogate model system of duck HBV (DHBV).
A novel carboxypeptidase (CPD, also designated gp180) has
been identified as a major pre-S binding protein and proposed
to be the potential DHBV receptor (12, 13, 30, 31, 32). Con-
sistent with this notion, CPD was shown to bind both viral
particles and recombinant L protein with high affinity (33).
More importantly, antibodies directed against CPD inhibit
DHBV infection of primary duck hepatocytes (PDHs) (33),
and heterologous expression of CPD leads to efficient inter-
nalization of viral particles in nonpermissive hepatoma cells
but is not sufficient to confer susceptibility to DHBV infection
(2, 11, 30). These studies suggest that additional or other
factors are required for the establishment of a productive in-
fection. Studies addressing the entry steps of the viral life cycle
are further complicated by the fact that hepadnavirus infection
leads to production of a huge excess of noninfectious, so-called
subviral particles (SVPs) in addition to progeny virus, which
makes the discrimination between SVPs and complete virions
in protein-based assays nearly impossible. These SVPs, which
are devoid of viral DNA and consist mainly of lipids and viral
envelope proteins, presumably compete with virions for the
same specific binding sites on hepatocytes (9). By using an
indirect immunoautoradiographic assay, binding of surface an-
tigen-containing DHBV particles to cells has been shown to be
species and cell type specific (22). Furthermore, it was shown
that attachment of viral particles to hepatocytes occurs in two
steps, involving an unspecific nonsaturable one with low affinity
followed by a second, saturable, high affinity binding one, as
demonstrated by competition experiments (9). DHBV inter-
nalization has been shown to require energy (10). Since hep-
adnaviruses are enveloped viruses, a fusion of virus and host
membranes must take place. Currently, there are only indirect
evidences for this postulated fusion event, which presumably
does not depend on low pH (10, 23). Regardless of which entry
pathway is used, core particles have to deliver their cargo, the
viral genome, into the nucleus, where the partially double-
stranded, relaxed circular viral DNA (rcDNA) is repaired and
converted into the so-called covalently closed circular DNA
(cccDNA) (for a review, see reference 6). This step is essential
and is a prerequisite for the establishment of a productive
infection by hepadnaviruses, since cccDNA is the central tem-
plate for viral transcription and replication (34).
To date, it is not known how the long distance between the
cell surface and the nucleus is overcome by hepatitis B viruses.
Upon entry, viruses often use the host cytoskeleton to move
within the cell toward their respective replication center (re-
viewed in references 20 and 25).
In the present study, we first developed an attachment and
postadsorption assay, after which we semiquantitatively inves-
tigated the timing and extent of infectious DHBV entry into
primary hepatocytes together with the cellular factors involved.
This approach revealed that DHBV entry and transport is
unusual in several aspects and includes new strategies not
reported for any other virus.
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MATERIALS AND METHODS
Primary hepatocyte cultures. Primary fetal duck hepatocytes were prepared
and cultivated as described elsewhere (21). PDHs were seeded into 12-well plates
at a density of about 5  105 liver cells per well.
Viruses, antibodies and drugs. PDHs were infected with a DHBV-viremic
goose serum containing about 1.1  1010 genome equivalents/ml, as determined
by DNA-dot blot analysis of viral particles in fractions obtained by CsCl centrif-
ugation using cloned DHBV DNA for calibration and containing about 1013
SVPs/ml. The approximate number of SVPs was calculated by measuring the
number of L-protein molecules with an immunoblot calibrated with highly pu-
rified recombinant pre-S protein (kindly provided by S. Urban, Heidelberg,
Germany) and based on the previously published educated guess that of the 100
envelope proteins of each viral particle about 20 are L-protein molecules (9, 24).
Paclitaxel (Molecular Probes), nocodazole, cytochalasin D, and suramin (all
from Sigma) were all reconstituted as 1,000-fold stocks in dimethyl sulfoxide and
stored at 20°C. The concentrations used were determined by dose escalation
experiments. Briefly, PDHs were pretreated with various concentrations of pac-
litaxel or nocodazole before and during inoculation with DHBV. Thereafter, the
drugs and the virus were removed, and the cells were further cultivated for 3 days
before harvest. The number of infected cells was determined by immunostaining
for L protein. For immunoblot and fluorescence analysis, we used rabbit anti-
DHBV-L-protein serum as previously described (21). Secondary goat anti-rabbit
antibodies conjugated with Alexa 488 or HRPO were obtained from Molec-
ular Probes or Dianova, respectively. Tetramethyl rhodamine isothiocyanate
(TRITC)-labeled phalloidin was obtained from Molecular Probes. For attach-
ment interference assays, we used three different rabbit anti-L-protein sera
(KpnI, DPSI, and pre-S 1-41), unrelated rabbit immunoserum, or mouse anti-
rabbit immunoglobulin G (IgG) (Sigma). The DPSI and KpnI antibodies were
raised against viral L-protein spanning amino acids 1 to 131 and 44 to 185 of the
L protein, respectively (28, 5). Pre-S 1-41 was raised against the N-terminal part
of recombinant pre-S and was kindly provided by S. Urban.
Attachment assays. To analyze the attachment of DHBV to cells with dis-
rupted cytoskeletons, cultures were pretreated with paclitaxel (10 M), nocoda-
zole (16.5 M), or cytochalasin D (20 M) for 1 h at 37°C, after which virus
inoculum was added and the cells were further incubated for 2 h at 4°C in the
presence of the drugs. The control cells were left untreated. After being washed
extensively with phosphate-buffered saline (PBS), the cells were lysed in 200 l
of PCR sample buffer, and PCR was performed (10).
To investigate the effect of neutralizing antibodies against L protein or
suramin on the attachment of DHBV to PDHs, viremic serum was preincubated
with 10 l of the different antibodies for 30 min at 37°C or cells were pretreated
with suramin (100 g/ml) for 1 h. Then inoculum was added to the treated cells,
or serum-antibody mixture was added to the untreated cells. Two hours after
transfer to 4°C, the cells were washed with PBS and lysed in 200 l of PCR
sample buffer or Laemmli buffer.
To test whether the extent of virus binding depends on the multiplicity of
genome equivalents (MGE) used, cells were exposed to different MGEs for 2 h
at 4°C or the incubation period at 4°C was changed. The cells were harvested as
described above. The amount of attached viral particles was extrapolated from
the L-protein levels determined by immunoblotting. Serial dilutions of the known
amount of recombinant pre-S protein were used for calibration. Signals were
quantified after acquisition with a Fluor-S MultiImager (Bio-Rad) by using
Quantity One software.
Protease protection assay. After attachment, the inoculum was removed, and
the cultures were washed with PBS and incubated with 1 ml of 0.25% trypsin-
EDTA solution per well for 10 min at 37°C. The cells were resuspended in the
trypsin solution, transferred to Eppendorf tubes, and pelleted by centrifugation.
The pellet was lysed in 200 l of PCR sample buffer.
Internalization assays. To investigate the internalization of DHBV in micro-
tubule (MT)-inactivated cells, the cultures were pretreated and incubated at 4°C
as described above. After 2 h of binding, the cells were washed three times with
PBS. New medium containing nocodazole or paclitaxel was added to the cells,
and the plate was transferred to 37°C. After 1, 3, and 9 h of incubation at 37°C,
the cells were rinsed with PBS and harvested as described in the protease
protection assay. The control cells without treatment were handled identically.
cccDNA isolation and amplification after disruption of MTs. The cells were
pretreated for 1 h with nocodazole, while the control cells were left untreated.
Then inoculum was added, and the cells were further incubated for 14 h. Virus
bound to the cell surface was inactivated by low-pH treatment (10), and the cells
were further cultivated in new medium containing no drug or nocodazole. The
cells were harvested at the indicated time points by trypsin treatment. cccDNA
was isolated according to a protocol described previously (27). The dried DNA
pellet was dissolved in 10 l of H2O, and 5 l of the solution was subjected to
PCR by using primer sets which allow preferential amplification of rcDNA
and/or cccDNA (10).
Infection assays in cells treated with cytoskeletal inhibitors. After a prepara-
tion step on day 3, the cells were preincubated with 10 M paclitaxel, 16.5 M
nocodazole, or 20 M cytochalasin D for 2 h, after which DHBV inoculum was
added. Infection was allowed to proceed for 14 h in the presence of the drugs.
Subsequently, the cells were washed with medium to remove unbound external
virus as well as the drugs. Following low-pH treatment, the cells were cultivated
in new medium for a further 3 days and harvested for immunoblot or immuno-
fluorescence analysis of L protein levels.
Cytotoxicity assay. Cells were treated with the indicated substances for 24 h,
washed with PBS, and subsequently incubated with 0.4% trypan blue in PBS for
3 min. After being washed with PBS, the cultures were investigated for blue cells,
and pictures were acquired. Parallel cultures were subjected to vitality assays
using fluorescein diacetate (FDA) (dissolved in dimethyl sulfoxide). After incu-
bation with FDA for 5 min at 37°C, the medium was changed, and pictures of
fluorescent cells were acquired by using an epifluorescence microscope.
Wash-out assay. The cells were exposed to DHBV at 4°C. After 2 h of binding,
the cells were washed three times with PBS to remove unbound virus. New
medium containing nocodazole was added, and the plate was transferred to 37°C
to allow virus internalization. After 30 min and 1, 2, 4, 6, and 8 h of incubation,
the cells were rinsed three times with PBS to remove unbound virus and the drug
to allow recovery of the cytoskeleton. Three days later, the cells were harvested
and stained or immunoblotted to determine L protein levels. The same proce-
dure was performed in parallel on nontreated control cells.
Add-in assay. Primary hepatocytes were treated with paclitaxel before or after
exposure to DHBV at the indicated time points. After a further 16 h of incuba-
tion, the cells were washed to remove the drugs and unbound virus. Virus that
was cell attached but still external was inactivated by a low-pH bath. Three days
following infection, the cells were harvested and subjected to immunoblot anal-
ysis to determine L-protein levels.
Transfection of PDHs and fluorescence microscopy. For visualization of the
microtubules, 2 days after being seeded on coverslips, PDHs were transfected
with 4 g of plasmid encoding tubulin-green fluorescent protein (GFP) (Clon-
tech) by using FuGene 6 according to the manufacturer’s instructions (Roche).
Germany Briefly, 80 l of culture medium without any supplements and 20 l of
FuGene 6 were mixed before 4 g of the plasmid was added. After being
incubated at room temperature for 5 min, 100 l of this mixture was added to the
cells, which were then incubated overnight at 37°C. One day after transfection,
the medium was removed and replaced with new medium. The transfection
efficacy examined by epifluorescence live-cell microscopy was usually less than
1%. The cells transfected with tubulin-GFP were either not treated or treated for
1 h with nocodazole. Recovery of the cytoskeleton was allowed in some samples
by washing with PBS and subsequent incubation for 1 h at 37°C. Following
mounting and embedding in Mowiol (Calbiochem, LaJolla, Calif.), fluorescence
was analyzed at room temperature with a Zeiss inverted epifluorescence micro-
scope S100 (Axiovert, Zeiss, Germany). Images were acquired and processed
with Openlab software.
For visualization of the actin fibers, PDHs were either treated or not treated
for 1 h with cytochalasin D. Recovery of the network was allowed in some
samples by washing with PBS and further incubation for 1 h without the drug.
Then the cells were washed twice with PBS and fixed with 3.7% paraformalde-
hyde. After being washed, the fixed cells were treated with ice-cold acetone for
5 min and washed again. The coverslips were blocked with 1% bovine serum
albumin in PBS for 30 min, after which TRITC-labeled phalloidin (stock, 50
g/ml diluted 1:100 in PBS) was applied for 30 min. After being washed with
PBS, the coverslips were incubated for a short time with 0.1% Triton X-100 in
PBS. The coverslips were washed for a short time with water and mounted in
Mowiol. Confocal images were acquired with the Zeiss confocal microscope
LSM 510 Meta.
Immunofluorescence analysis. The cultures were washed once with PBS and
fixed with an ice-cold mixture of methanol and acetone (1:1) for 10 min at room
temperature. The cells were rehydrated with PBS and incubated for 1 h at 37°C
with rabbit anti-DHBV-L-protein serum KpnI diluted 1:800. The cells were then
washed three times with PBS and incubated at 37°C with secondary goat anti-
rabbit Alexa 488-labeled (green) antibody (diluted 1:800) for another 30 min.
Nuclei were counterstained with Hoechst (final concentration, 4 g/ml). The
stained cells were washed with PBS and analyzed and photographed directly in
the well. Pictures were taken with the same equipment as described above but
with a 10-fold objective and a numerical aperture of 0.30. No L-protein signals
were observed with cells incubated with a MGE of 220 for up to 36 h following
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removal of the inoculum by washing of the cells, indicating that positive staining
in our system represents a reliable marker for de novo infection.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot-
ting. The cells were washed with PBS and directly lysed in 200 l of 4 Laemmli
buffer per well. All samples were boiled for 5 min, and 20 l of each sample was
fractionated by denaturating sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. Subsequently, proteins were transferred onto nitrocellulose mem-
branes. Following blocking with 3% dried milk diluted in Tris-buffered saline
(TBS; 50 mM Tris-HCl–150 mM NaCl), the membranes were incubated for 1 h
at room temperature with rabbit anti-DHBV-L-protein serum KpnI (diluted
1:20,000). After several washings with TBS plus 0.1% Tween 20, the membranes
were further incubated with horseradish peroxidase-coupled goat anti-rabbit IgG
antibodies at a dilution of 1:20,000. Proteins were visualized by enhanced indirect
chemiluminescence by using SuperSignal Pico West (Pierce) substrate. Signals
were quantified after acquisition with a Fluor-S MultiImager by using Quantity
One software.
RESULTS
Attachment and internalization kinetics of DHBV in pri-
mary hepatocytes. As a first step towards delineation of the
nature and number of cellular factors restricting hepadnavirus
infection in vitro, we analyzed viral attachment and entry ki-
netics by using DHBV-permissive PDHs. The cell cultures
were exposed for 2 h at 4°C to DHBV at different MGEs
ranging from 1 to 1,100. Subsequently, the cells were washed
and harvested, and the amount of cell-associated viral DNA
was semiquantitatively determined after agarose gel electro-
phoresis of amplified PCR products. Serial dilutions of a
DHBV-viremic serum with known genome equivalents (GE)
included in the PCR run revealed an assay sensitivity of about
103 GE and linearity between 103 to 106 GE (Fig. 1A, lanes 6
to 9). According to this assay, the amount of attached virions
proportionally increased with the MGE (Fig. 1A, lanes 1 to 5).
Based on comparative analysis of the PCR signals obtained
from 5  105 hepatocytes inoculated with different MGEs
together with those of the standard used, the average number
of virions attached at 4°C during 2 h was estimated to be about
10 per cell (ranging from 1 to 10 in different experiments).
Determination of the amount of viral particles in the inoculum
before and after incubation with PDHs revealed very similar
levels of L protein and viral DNA, as analyzed by immuno-
blotting and PCR, respectively (data not shown), indicating
that only a minute fraction of the virus input (about 0.05%)
bound to cells.
A peculiarity of all hepadnavirus infections is the huge over-
production of SVPs lacking viral DNA and core protein. To
FIG. 1. Binding and internalization kinetics of DHBV in PDHs. (A) To analyze binding of virions to hepatocytes, cells were incubated with
DHBV at different MGEs for 2 h at 4°C, washed, harvested, and subjected to DHBV DNA-specific PCR. Serial dilutions of viremic serum were
included as a standard. To test the effect of independent neutralizing antibodies (KpnI, DPSI, and 1-41) and suramin (Sur.) on virus attachment,
inoculum containing 220 MGEs and cells were preincubated with the antiserum and suramin, respectively, for 30 min at 37°C prior to the
attachment assay. Native rabbit serum (RS) and rabbit anti-mouse IgG (IgG) served as controls. The cells were preincubated with suramin for 1 h
before the attachment assay was performed. (B) The MGE dependency and specificity of SVP binding to hepatocytes was investigated as described
above. Serial dilutions of recombinant pre-S protein with a known protein concentration were included as a standard, and 20 molecules thereof
were considered equivalent to one viral particle. The L protein in all immunoblots shown was detected with KpnI antiserum. T and T, harvest
without and with trypsin, respectively. (C) Time course of DHBV binding to PDHs. Cultures were incubated with increasing MGEs for the
indicated time points at 4°C. Subsequently, the cells were harvested, and the amount of cell-associated virions was determined by PCR. (D) Time
kinetic of DHBV entry into PDHs. DHBV was allowed to attach to hepatocytes for 2 h at 4°C. Thereafter, the cells were immediately harvested
by direct lysis after trypsin treatment or washed and shifted to 37°C in new medium to allow virus internalization. At the indicated time points,
the cells were harvested by limited protease digestion to remove bound external virus and were analyzed for intracellular viral DNA by PCR. Serial
dilutions of DHBV-viremic serum with 1.1  1010 GE served in every PCR as a standard.
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answer the question of whether abundant natural SVPs present
in DHBV-viremic serum are as binding-competent as the ac-
companying virions, we performed analogous experiments as
described above and estimated the amount of bound SVPs by
semiquantitative immunoblot analysis for L protein. Serial di-
lutions of a recombinant duck pre-S protein revealed a sensi-
tivity of about 107 SVPs (data not shown) and a dose-depen-
dent increase of between 108 and 1010 SVPs (Fig. 1B, lanes 6
to 8). This analysis indicated that the fraction of SVPs bound
to hepatocytes was directly proportional to the amount of
DHBV-positive serum applied to the cultures (Fig. 1B, lanes 1
to 4) and paralleled that of DNA-containing particles (Fig. 1A,
lanes 1 to 5). Trypsin treatment of the cells prior to lysis
virtually removed the signal originating from cell-bound SVPs
(Fig. 1B, lane 5), excluding internalization of a significant frac-
tion of viral particles under the conditions used. Based on the
quantification of the immunoblot using standard dilutions of
recombinant pre-S protein (Fig. 1B, lanes 6 to 8), we estimated
the average number of SVPs which bind to hepatocytes during
2 h at 4°C when 5 105 cells are incubated with a MGE of 220
to be about 10,000. This calculation is based on the reported
educated guess that one viral particle contains about 20 L-
protein molecules (9, 24).
The specificity of virion and SVP binding was evaluated by
the use of neutralizing antibodies or drugs in attachment in-
terference experiments. Preincubation of the virus inoculum
corresponding to a MGE of 220 with three independent L-
protein antisera (KpnI, DPSI, and/or 1-41; see Material and
Methods) strongly reduced binding of virions (Fig. 1A, lanes 10
to 12) and SVPs (Fig. 1B, lanes 9 to 12 and 16) to hepatocytes,
while control rabbit serum or immunopurified mouse anti-
rabbit IgG did not show any significant interference (Fig. 1A,
lanes 14 and 15, and Fig. 1B, lanes 13 and 14). As the pre-S
region of the L protein is known to mediate virus-hepatocyte
interaction essential for productive infection (6), this finding
implies that most of the virus binding under our experimental
conditions is specific and relevant for productive infection.
Suramin, a known inhibitor of DHBV infection (17), reduced
attachment of both DNA-containing particles and SVPs to an
extent similar to that of the neutralizing antibodies (Fig. 1A,
lane 13, and Fig. 1B, lane 15), indicating that the well-known
antiviral effect of suramin is due mainly to its interference with
virus attachment. This finding further corroborates the physi-
ological relevance of virus-binding sites for productive DHBV
infection measured in our assay. In addition, the results suggest
that under our experimental conditions both SVPs and virions
bind to primary hepatocytes, with similar kinetics and effi-
ciency.
We next examined the kinetics of virion binding to cells and,
in particular, whether binding is saturable under our experi-
mental conditions. To determine the time dependency of viral
attachment to hepatocytes, the cells were incubated with in-
creasing MGEs for different time periods at 4°C. Thereafter,
unbound viral particles were washed off, the cells were lysed,
and the amount of cell-associated viral DNA was determined
by PCR. According to this assay, at 220 MGEs virus attach-
ment was already detectable 30 min after virus inoculation and
the signal increased proportionally with incubation time and
reached a maximum between 2 and 4 h (Fig. 1C, lanes 4 to 8,
MGE 220). These data indicate that at the MGE used, the
majority of hepatocellular binding sites were occupied within 2
to 4 h of virus inoculation. However, the time course and
extent of virion binding was dependent on the MGE used, as is
evident from the further increase of signals when the MGE is
tripled to 660. Under these conditions, the signals were already
saturated 1 h after inoculation (Fig. 1C, lanes 4 to 8, MGE
660). A further increase in MGE had an effect on neither the
time kinetics nor the extent of virus binding (Fig. 1C, lanes 4 to
8, MGE 990), which indicates that saturating conditions had
been reached. Taken together, these data suggest that most of
our experiments done at a MGE of 220 were performed close
to saturating conditions and imply that the number of hepato-
cellular binding sites for viral particles is limited in the system
used. Exposure of PDHs for up to 6 h to 4°C did not result in
any detectable morphological alteration of hepatocytes, as de-
termined by light microscopy. Moreover, no difference was
observed in the number of trypan blue-stained cells in treated
or untreated cultures. The viability of cells tested by vital stain-
ing with fluorescein diacetate was also not affected. These
results clearly indicate that the cultures tolerate the incubation
at 4°C for up to at least 6 h without gross morphological and
functional impairment (data not shown).
To determine how fast and how much of the attached virus
enters the cells, we performed a protease protection assay.
This assay is based on the assumption that, once inside the cell,
a virus is protected from degradation by an extracellularly
added protease. In our experiments, cells were exposed to
DHBV for 2 h at 4°C and nonbound virus was removed by
washing. Then the cells were harvested either directly or after
10 min of trypsin treatment. Parallel cultures were shifted to
37°C for 1, 3, and 9 h to allow for internalization, trypsin-
treated subsequently to remove cell surface-bound virus, and
harvested, and the amount of cell-associated viral DNA was
determined by PCR. In these experiments, 90% of attached,
but not yet internalized, virions could be removed by trypsin
(Fig. 1D, lanes 2 and 3), indicating that at 4°C virtually all
virions were cell surface located. Interestingly, after incubation
of the cells at 37°C for only 1 h following attachment about
70% of initially attached DHBV became protease resistant
(Fig. 1D, lane 4); this fraction increased to 100% after incu-
bation for a further 2 h (Fig. 1D, lane 5). A more-detailed
kinetic analysis revealed that DHBV entry began after the shift
to 37°C, with a delay of about 30 min (unpublished data). From
these experiments, we conclude that almost all virions which
attached to the cell surface were internalized and that attach-
ment was fully accomplished in less than 3 h.
In summary, our data demonstrate that only a very small
percentage of total virions added to the cell culture medium
binds to and enters into hepatocytes within 3 h, but incoming
viral rcDNA is repaired in the nucleus and can be detected as
cccDNA only after a time period of unprecedented length, 20 h
after infection (11, 22).
Disruption of the cytoskeleton increases viral attachment to
hepatocytes. In light of the previous findings, one wonders if
DHBV fails to take advantage of energy- and cytoskeleton-
dependent pathways for its intracellular transport, unlike what
is reported for many other viruses. To examine whether the
cytoskeleton is exploited during viral entry into duck hepato-
cytes, we first determined the effects of three drugs that inter-
fere with cytoskeleton structure and function on DHBV at-
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tachment: cytochalasin D and nocodazole, which specifically
depolymerize actin and tubulin filaments, respectively, and
paclitaxel, which prevents dynamic turnover of MTs by stabi-
lizing them. Treatment of PDHs with cytochalasin D and no-
codazole for 1 h completely depolymerized actin and tubulin
filaments, respectively, as was evident from drastic changes in
the cytoskeleton network visualized by fluorescence micros-
copy of TRITC-phalloidin-stained actin (Fig. 2A, left panel)
and ectopically expressed tubulin-GFP (Fig. 2A, right panel) in
PDHs. In marked contrast to untreated cells, which had arrays
of actin microfilaments, cytochalasin D-treated cells exhibited
a granular pattern of actin, indicating efficient fragmentation
of the actin network (Fig. 2A, panels labeled Actin). Tubulin-
GFP-transfected PDHs showed strong fluorescence at the nu-
clear rim, from which fine bundles of MTs were emanating, a
pattern diverging for unknown reasons from that seen in hep-
atoma cell lines. Following treatment with nocodazole, the
filamentous MT pattern collapsed and became predominantly
diffuse (Fig. 2A, panels labeled Tubulin-GFP). Careful exam-
ination by light microscopy revealed no gross morphological
changes in drug-treated PDHs (Fig. 2A, panels labeled Phase
Contrast). Removal of the drugs resulted in reorganization of
the cytoskeleton after about 30 min, indicating that their effects
are reversible (unpublished data).
After successful demonstration of drug-induced cytoskele-
ton inactivation, we determined potential effects of the drugs
on DHBV attachment. Cells were pretreated for 1 h with
cytochalasin D, nocodazole, or paclitaxel before exposure to
DHBV for 2 h at 4°C. The cultures were then washed and
harvested by direct lysis, and the amount of bound DHBV was
determined by PCR. Disruption of the actin and tubulin net-
work by cytochalasin D or nocodazole prior to adsorption had
no negative effect on virus attachment but strongly increased
the attachment of virions compared to that for untreated cells
(Fig. 2B, lanes 2, 4, and 6). The MT-stabilizing drug paclitaxel
had no influence on DHBV binding (Fig. 2B, lanes 2 and 5).
Taken together, our data indicate that an intact cytoskeleton is
dispensable for attachment of DHBV to hepatocytes and sug-
FIG. 2. (A) Visualization of the organization of actin and the tubulin network and their disruption in PDHs. Cells were treated for 1 h with
cytochalasin D (Cyt. D), and subsequently, the actin fibers were stained with TRITC-labeled phalloidin. Primary hepatocytes expressing GFP-
conjugated tubulin were treated for 1 h with nocodazole (Noco.). Fluorescence and corresponding phase contrast images of the same field are
shown, as well as pictures from untreated control cultures. (B) The effect of cytoskeleton-disrupting drugs on the binding of DHBV to hepatocytes.
Cells were pretreated with cytochalasin D, nocodazole, or paclitaxel (Pacli.) for 1 h before DHBV was added to the cells for 2 h at 4°C.
Subsequently, the cells were harvested, and bound viral DNA was determined by PCR. In one sample (lane 3), the external virus was removed with
trypsin before harvest.
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gest the existence of some cryptic virus binding sites, which
become accessible after treatment of cells with cytoskeleton-
disrupting, but not MT-stabilizing, drugs.
To exclude the possibility that the effects seen in our exper-
iments result from unspecific cytotoxic side effects of the drugs,
we treated persistently infected PDHs with the substances for
24 h and then tested viability with trypan-blue dye exclusion, by
FDA staining, and morphologically by light microscopy. None
of these assays showed any signs of cytotoxicity which could
account for the interference with DHBV infection (data not
shown). Moreover, none of the drugs affected ongoing intra-
cellular viral gene expression in chronically infected PDHs, as
tested by immunoblotting of cell lysates for the viral and cel-
lular proteins L and actin, respectively (data not shown).
Actin cytoskeleton is dispensable for productive viral infec-
tion. Next, we asked whether virus entry or intracellular traf-
ficking depends on the actin network. To answer this question,
PDHs were pretreated with cytochalasin D for 2 h at 37°C and
subsequently exposed to DHBV with the drug still present.
After 14 h of incubation, the drug and unbound virus were
removed by washing the cells with PBS. In addition, surface-
attached, but not yet internalized, virus was inactivated by a
brief shift to low pH, and then medium without inhibitor was
added. Three days after treatment and infection, the cells were
harvested, and the efficiency of infection was estimated by
analysis of the number of infected cells and the level of intra-
cellular viral protein expression by indirect immunofluores-
cence staining and immunoblotting for the L-protein, respec-
tively. Cytochalasin D treatment had no negative effect on
infection and even slightly increased the number of infected
cells compared to untreated cells (Fig. 3A). Immunoblot anal-
ysis of cell extracts showed elevated L-protein signals in the
treated cells compared to those of the nontreated cells (Fig.
3B, lanes 2 and 3) and thus corroborated this finding. These
data are consistent with the increase in virus attachment to
cytochalasin-treated cells shown above (Fig. 2B, lanes 2 and 6)
and indicate that the actin cortex and filaments are not essen-
tial for infection and may even pose a hindrance. Taken to-
gether, our data show that strictly actin-dependent processes
are not required for viral entry or trafficking to initiate a pro-
ductive infection in primary hepatocytes.
MTs are essential for productive viral infection of hepato-
cytes. Since actin filaments are dispensable for DHBV infec-
tion, we next asked whether the same applies to MTs. For
inactivation of MTs, cells were pretreated with nocodazole or
paclitaxel for 2 h before virus inoculation and then further
incubated in the presence of the drug and the virus for 14 h at
37°C. Nonbound virus and drugs were then washed away and
cell-bound, noninternalized virus was inactivated by low-pH
treatment for 2 min. The cells were further incubated at 37°C
for 3 days, harvested, and tested for indicators of ongoing viral
replication by indirect immunofluorescence staining and im-
munoblotting. Immunostaining for L protein revealed no or
very few positive hepatocytes in nocodazole- and paclitaxel-
treated cultures compared to about 104 L-protein-positive cells
in the nontreated control well (Fig. 4A), indicating that infec-
tion was almost completely inhibited by both drugs. Drastically
lower levels of intracellular L protein detected by immunoblot-
ting in treated cells (Fig. 4B, lanes 1 to 6) support this conclu-
sion. The antiviral effects were observed with doses as low as
100 nM paclitaxel and 1.65 M nocodazole, which are nontoxic
concentrations for PDHs, as analyzed by various vitality assays
mentioned above and in the Materials and Methods section
FIG. 3. The actin cytoskeleton is dispensable for the infectious entry of DHBV in primary hepatocytes. The actin cytoskeleton was disrupted
by cytochalasin D treatment for 2 h before virus inoculation for 16 h with the drug still present. After being washed and receiving pH shock, cells
were cultivated in new medium for a further 3 days before harvest. Cultures were analyzed for L-protein expression by immunostaining (A) and
-blotting (B). Fluorescence and phase contrast images of the same field of treated and untreated cells are shown. The corresponding immunoblot
analysis is shown on the right.
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(data not shown). These findings indicate that without func-
tional MTs during the first 14 h of virus entry and trafficking,
establishment of a productive infection is extremely inefficient.
Furthermore, our data clearly demonstrate that DHBV needs
both intact and dynamic MTs. Their inactivation for 16 h early
in viral infection interferes irreversibly with the establishment
of infection.
MTs are not required for internalization of DHBV in PDHs.
Since virus attachment to hepatocytes was not dependent on
MTs, we next asked whether inhibition of DHBV infection by
nocodazole and paclitaxel was due to failure in virus internal-
ization. If true, no virus inoculum or only a small amount of
virus inoculum should be internalized in drug-treated cells
compared to that for nontreated cells. This difference should
be detectable in the protease protection assay used above (Fig.
1D) and was therefore experimentally tested. After being pre-
treated and incubated for 2 h with DHBV and drugs at 4°C, the
cells were washed and harvested by lysis, and the amount of
bound virus was determined by PCR (Fig. 5, lane 2). Trypsin
treatment of the cells prior to lysis reduced the amount of
cell-bound virus to about 10% compared to that for nontreated
cells (Fig. 5, lanes 2 and 3), consistent with results shown above
(Fig. 1D). In order to determine how much of the attached
virus enters drug-treated and nontreated cells under these con-
ditions, parallel cultures were transferred to 37°C and further
incubated for 1, 3, and 9 h in new medium with or without the
drugs. Cell surface-bound, but not yet internalized, virus was
then removed by trypsin treatment. Determination of the frac-
tion of protease-protected, intracellular viral DNA showed no
difference between that for drug-treated and nontreated cells
(Fig. 5, lanes 1 to 6). These data indicate that neither disrup-
tion of MTs by nocodazole nor prevention of their dynamic
turnover by paclitaxel has any detectable influence on the ef-
ficiency and kinetics of DHBV internalization. Therefore, the
block of DHBV infection by both drugs is presumably due to a
postentry event.
FIG. 4. MTs are essential for the establishment of DHBV infection in primary hepatocytes. MTs were disrupted or stabilized by nocodazole
(Noco.) or paclitaxel (Pacli.) treatment, respectively, for 2 hours before exposure to virus for 16 h in the continuous presence of the drugs. After
the virus and drugs were removed by washing and pH shock, the cells were further cultivated in new medium for 3 days. Afterward, they were fixed
for immunostaining (A) or harvested for detection of L protein by immunoblotting (B).
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MT-dependent virus trafficking is vulnerable only at spe-
cific, early entry time points. The data obtained so far indicate
that MTs play a critical role in a postentry step, which raises
several interesting questions. For instance, from which time
point on after virus uptake and for how long thereafter are
MTs required for the establishment of infection? Moreover, is
there a critical time period when MT inactivation leads to an
irreversible block of virus infection, and if so, what are the
underlying mechanisms? To answer these emerging questions,
we first determined at which time point upon viral entry MTs
become dispensable for productive infection by employing an
add-in experiment. Cells were treated either 0.5 h prior to or at
different time points (0.5 to 12 h) after exposure of cultures to
virus with paclitaxel or nocodazole. Non-cell-associated and
noninternalized viral particles were washed off after 16 h of
further incubation and inactivated by low-H treatment. The
cells were thereafter maintained for a further 3 days in medium
devoid of any drug or virus. As an indirect measurement of the
level of productive infection that had occurred, steady-state
levels of intracellular L protein were determined. This add-in
assay revealed very low infection efficiency when cells were
treated prior to infection and up to 4 h postinfection compared
to that for nontreated cells (Fig. 6A, lanes 2 to 6). Paralyzing
MTs 8 to 12 h after virus inoculation led to increasingly higher
levels of L-protein expression, indicative of a parallel increase
in productive DHBV infection compared to that for cells
treated with drugs at earlier time points (Fig. 6A, lanes 2 to 8).
Similar results were obtained with nocodazole (unpublished
data). These findings demonstrate that successful intracellular
trafficking of DHBV depends on a MT-sensitive step very early
in infection (0 to about 4 h after viral entry), while MTs
become increasingly dispensable thereafter. Thus, disturbance
of viral trafficking at very early stages led to almost complete
elimination of the infection. Unexpectedly, this was irrevers-
ible because infection did not occur despite the removal of
MT-inactivating drugs 22 h after infection, which predictably
led to fast reformation of MTs for about 3 days before the cells
were harvested. A possible explanation for this irreversible
infection block is the assumption that internalized, but ar-
rested, virus particles are unstable and are rendered noninfec-
tious, which implies that cellular enzymes cannot degrade viral
or subviral particles efficiently after entry as long as they are
residing in certain cellular compartments for only limited time
periods. This seems most likely to be the case during the first
3 to 4 h after infection and, if correct, predicts that destruction
and reformation of MTs during this period should not pose any
risk for the infectivity of intracellular viral particles. Therefore,
reconstitution of the MT network up to about 4 h after virus
uptake should lead to productive infection, whereas reforma-
tion at later time points should not lead to productively in-
fected cells. We have tested this hypothesis experimentally in a
wash-out assay by allowing DHBV to bind to cells for 2 h at
4°C. The nonbound virus was subsequently removed, and new
medium containing nocodazole or no drug was added to the
cells before shifting them to 37°C to initiate a nearly synchro-
nous internalization. Nocodazole was removed at different
time points (0.5 to 8 h) after shifting the cultures to 37°C to
allow reformation of MTs. Thereafter, the cells were further
incubated for 3 days, harvested, and analyzed for signs of
productive infection. Detection of L protein in cell lysates by
immunoblotting revealed no or little negative effect on PDH
infection after treatment with nocodazole for up to 2 h (Fig.
6B, lanes 8 to 10). Increasing inhibition of infection was ob-
served in this assay when the drug was washed out after 4 to 8 h
(Fig. 6B, lanes 11 to 13). Immunostaining of cells for L-protein
expression corroborated these results and, moreover, demon-
strated that inhibition of infection is predominantly due to
reduced numbers of infected cells rather than to lower L-
protein expression levels in infected individual cells (Fig. 6C).
Taken together, these data are in perfect agreement with our
prediction that destruction of MTs within the first 4 h after
virus uptake does not interfere with infection when MTs are
allowed to reform thereafter. However, destruction of MTs for
FIG. 5. MTs are required for a postentry step of DHBV other than attachment and internalization. PDHs were treated with nocodazole or
paclitaxel for 1 h at 37°C before being inoculated with DHBV at 4°C for 2 h. The cells were harvested immediately or after trypsin digestion or
shifted to 37°C to allow internalization of bound viral particles. At the indicated time points, cells were harvested by limited protease digestion and
analyzed for intracellular viral DNA by PCR.
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longer time periods leads to an irreversible abortion of viral
infection.
Lack of cccDNA formation without intact MTs. The data
outlined above indicate that MTs are indispensable for an early
step subsequent to virus internalization. In order to elucidate
whether this step occurs before or after nuclear transport of
the viral genome, we determined the amount of intranuclear
viral cccDNA produced from incoming partially double-
stranded genomes by repair in MT-disrupted cells. This repair
reaction, converting incoming rcDNA into cccDNA, is com-
pleted after about 20 h following viral entry, after which a
cccDNA pool that indicates successful viral entry is established
(11, 22). To test the effect of nocodazole on nuclear viral
genome transport, PDHs were pretreated with nocodazole for
1 h. Afterwards, virus inoculum was added, and the cells were
incubated for 20 h at 37°C with the drug still present. Virus
attached to cells was inactivated by treatment with low pH.
New medium containing nocodazole was added, and 20, 40,
and 60 h later, cells were harvested for PCR analysis that
preferentially detects cccDNA. In this assay, there was no
cccDNA detectable in the absence of functional MTs (Fig. 7,
lanes 2, 4, 6, and 8). Since nocodazole does not affect virus
FIG. 6. Disruption of microtubules induces an irreversible postentry block leading to abortion of DHBV infection. (A) Primary hepatocytes
were treated with paclitaxel before or after exposure to DHBV at the indicated time points. After a further 16 h of incubation, the cells were
washed, and external virus was inactivated by a low-pH wash. Three days following inoculation, the cells were harvested and subjected to
immunoblot analysis for L protein. (B and C) The inverse wash-out experiment. Cells were exposed to the virus for 2 h at 4°C. The cultures were
then washed with PBS, and new medium containing nocodazole or no drug was added. After the cultures were shifted to 37°C, the drug was
removed at the indicated time points by washing and the addition of new medium. Three days later, the cells were harvested and immunoblotted
(B) or -stained (C) for L protein. Nuclei were counterstained with Hoechst.
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binding to, and internalization into, hepatocytes, we conclude
from this experiment that MTs are essential for a postentry
step prior to viral genome delivery into the nucleus. Our data
indicate that MTs play a critical role in a transport step occur-
ring after virus attachment and internalization and prior to
arrival of incoming viral genomes in the nucleus.
DISCUSSION
The molecular characterization of viral and cellular compo-
nents acting at early stages of host-virus interaction is of key
importance, since these factors mainly determine the host
range, tissue tropism, and pathogenicity of viruses. For the
hepatitis B virus, one of the major human viral pathogens, it
has been difficult to study authentic interaction of the virus
with hepatocytes.
To address this issue, we established a sensitive assay, allow-
ing for the first time the quantification of the time dependence
of both virion and subviral particle binding to primary liver cell
cultures. This binding assay revealed a specific and dose-de-
pendent increase of virion and SVP binding to hepatocytes.
The results are strongly supported by the elegant experiments
of Pugh et al., showing that the cellular binding of surface
antigen-containing DHBV particles is cell type and species
specific (22). Our attachment experiments with a viremic se-
rum containing both virions and natural SVPs demonstrate
that the number of binding sites on hepatocytes is limited and
relatively low, with an estimated number of about 104 per cell.
This number was calculated from the amount of L-protein
molecules bound in the form of viral particles to hepatocytes,
as measured by semiquantitative immunoblotting standardized
with known amounts of recombinant pre-S protein and by
taking into account the reported educated guess of 20 L-pro-
tein molecules per viral particle (9, 24). The kinetics and effi-
ciency of SVP binding to cells were comparable to and paral-
leled that of accompanying virions, suggesting that they are
similar in their attachment capability and probably compete for
the same cellular attachment sites as previously suggested (9).
The latter conclusion was further substantiated by our data
showing that neutralizing antibodies and suramin interfere
with attachment of both virions and SVPs. However, our data
do not exclude possible differences in binding kinetics and
efficacy between virions and SVPs when tested separately, be-
cause putative cooperative effects would not be visible. This
speculation is compatible with the enhancement of infection by
SVPs described previously (3). Determination of the time
course of virion binding at different MGEs revealed that virus
attachment is time dependent and can be saturated. Together
with the fact that the saturation can be achieved earlier with
higher MGEs indicates that the number of hepatocellular
binding sites is indeed limited.
Using a protease protection assay to specifically follow the
timing of DHBV entry, we found that bound viral particles are
taken up with rather slow kinetics compared to those for Sem-
liki Forest virus and adenovirus (20, 25), which both enter host
cells by clathrin-coated, pit-mediated endocytosis within about
10 min instead of the more than 1 h needed by DHBV. In this
respect, DHBV is similar to simian virus 40 (SV40), which is
internalized within 2 h (1). The relatively slow entry kinetics of
DHBV might be a consequence of slow two-step kinetics of
receptor binding and/or subsequent coreceptor recruitment,
probably similar to that described for SV40 (1).
The time period required until the first copy of hepadnavirus
cccDNA is formed after infection was reported to be about
20 h (11, 22). Taking this and our evidence for a maximal time
requirement of 3 h for virion entry into consideration, there
are at least 14 h left for cytoplasmic trafficking of viral particles,
nuclear delivery, and conversion of the viral genome from
rcDNA into cccDNA. This long period may be due to an
unusual restrictive process during cytoplasmic and nuclear
trafficking or conversion from rcDNA to cccDNA that is
unique to hepadnaviruses. In any case, our results suggest a
rate-limiting postentry step for hepadnaviruses so far not re-
ported for any other virus, and a detailed understanding of this
step may reveal strategies also exploited by other viruses for
which intracellular trafficking has so far not been analyzed.
The cytoskeleton is likely to be involved in virus attachment
and may critically contribute to this step by, for example, main-
tenance of plasma membrane structures. However, our data
indicate that both intact actin filaments and microtubules are
dispensable for adsorption of DHBV to hepatocytes and sug-
gest the existence of some cryptic virus binding sites which
become accessible after treatment of cells with cytoskeleton-
disrupting, but not -stabilizing, drugs. Cell-cell junctions, mi-
crovilli, and invaginations may harbor such cryptic sites (14).
Since formation of these structures depends at least in part on
the cytoskeleton, the diffusion-controlled access of virus to
such binding sites may be facilitated by drug-induced destruc-
FIG. 7. Lack of cccDNA in MT-disrupted cells. PDHs were pretreated with nocodazole for 1 h prior to virus exposure and further incubated
for 20 h in the presence of the drug. Afterward, bound but not internalized virus was inactivated by a low-pH wash. New medium containing no
drug or nocodazole was added, and cells were harvested 20, 40, and 60 h later, after trypsin treatment. The cccDNA was detected by PCR by using
gap region-specific primers.
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tion of the cytoskeleton. According to our data, disruption of
the submembranous, dense actin cortex has no negative impact
on the efficiency of DHBV entry, cytoplasmic trafficking, and
nuclear genome transfer. This finding is remarkable, given the
fact that human immunodeficiency virus, adenovirus, SV40
virus, and vaccinia virus all require actin for uptake and estab-
lishment of infection (for reviews, see references 20 and 25 and
references therein) and thus points to another distinct feature
in the early stage of the hepadnavirus life cycle.
Once inside the hepatocyte, incoming DHBV virions have to
deliver their cargo, the viral genome, to the nucleus to launch
viral replication. Directional transport of incoming viral parti-
cles, free or membrane bound, most likely involves the host
cytoskeleton. The data outlined in this study suggest that in
contrast to actin filaments, MTs play an essential role early in
DHBV infection. Furthermore, successful trafficking of incom-
ing viral particles requires both intact and dynamic MTs.
DHBV diverges in this requirement from all other viruses,
according to our knowledge (7). For instance, the intracellular
transport of papovaviruses depends on the intactness (which
can be disrupted by nocodazole) but not on the dynamic turn-
over (which can be prevented by paclitaxel) of MTs (15). Our
data are consistent with the notion that viruses depend on
cytoskeletal elements for their intracellular motility and pro-
vide a novel example of the variation in strategies employed by
different viruses.
The inhibition of DHBV infection in cells without functional
MTs was strong but not complete. The residual low level of
infection observed in treated cells may be due to incomplete
drug-mediated MT inactivation or the existence of a minor,
MT-independent infection pathway which may include cyto-
plasmic trafficking by diffusion. Alternatively, after reforma-
tion of MTs, a few intracellular viruses may be able to reach
the nucleus and manage to establish a low level of infection. In
addition, Glu-tubulin, a nocodazole-resistant minor variant of
alpha-tubulin (29, 8), might be able to rescue the transport of
DHBV to a small extent after nocodazole treatment.
Our data show that MTs are essential for a postentry step in
the viral life cycle, since there was no negative interference
with the kinetics or extent of viral uptake in hepatocytes with
nonfunctional microtubules. This notion together with the ab-
sence of any cccDNA formation in cells with disturbed MTs
strongly suggests that MTs play a pivotal role in an entry step
occurring after virus binding and uptake and prior to the nu-
clear delivery of incoming viral genomes. However, two ques-
tions remain: which of the several distinct early steps is depen-
dent on microtubules, and which mechanisms are involved?
The correlative kinetic analysis of MT disturbance and DHBV
infectivity revealed that the entry-limiting microtubule-sensi-
tive step occurs between 4 and 8 h postinfection. Depolymer-
ization and reformation of the MTs at 4 h after viral entry or
earlier did not interfere significantly with productive infection.
Disruption followed by reformation of MTs after this time
period led to almost complete elimination of infection. These
findings indicate that the infectivity loss of intracellular viral
particles by arrest of MT-mediated motility is irreversible dur-
ing a certain early stage in the viral life cycle. The basis for this
unusual finding is unclear at present, and we know of no
precedent in the animal viruses to explain this peculiar irre-
versible abortion of viral entry (16, 18, 26). Intracellular viral
particles, free or in vesicles, seem to maintain their infectivity
as long as they are arrested for only limited time periods and
reside in certain cellular compartments independent of their
connection to MTs. Extension of this transport block results in
rapid loss of viral infectivity pointing to a MT-dependent and
strictly regulated key event in the viral life cycle. In the case of
SV40, it has been reported that the MT-dependent step occurs
between 3 and 6 h after infection and is required for transport
of SV40 between the caveosome and smooth endoplasmic re-
ticulum-derived perinuclear tubules (19). Although endocyto-
sis has been suggested as an entry route for DHBV (10),
its mode and the subsequent uncoating steps are unknown.
Therefore, it is currently impossible to link our data to certain
stages of hepadnavirus entry. However, the MT-sensitive step
in the infectious entry pathway may reflect an analogous trans-
port step and likely involves MT-mediated core and genome
transport. This speculative assumption is compatible with our
finding that, in hepatocytes lacking functional MTs, the viral
genome does not arrive in the nucleus and is not converted to
cccDNA and amplified. Not mutually exclusive to that finding,
hepadnavirus genome transport may depend on an uncoating
and core maturation process facilitated by association of the
viral particles with MTs. Indeed, MTs serve as a favored site
for maturation of viral particles upon entry, as previously re-
ported for human immunodeficiency virus (4).
Continuous block of the timely coordinated, intracellular
trafficking of viral particles may finally increase their suscepti-
bility toward proteolytic processing and destruction. Confor-
mational changes in structural proteins, particularly the enve-
lope proteins, which are thought to occur upon attachment,
entry, and uncoating of DHBV, might explain their enhanced
susceptibility for degradation. Incoming viral particles and pro-
teins may already be sensed and attacked in the cytoplasm by
the proteolytic machinery of the host cell. In line with this
notion, we found that one of the most critical components of
the viral envelope, the L protein, is very unstable and rapidly
cleared by cellular proteases, predominantly but not exclu-
sively involving the proteasome (unpublished data).
The infectious entry pathway of hepadnaviruses clearly in-
volves a series of highly coordinated and vulnerable steps prior
to arrival of the viral genome in the nucleus, initiating produc-
tive infection. The persistent failure to propagate HBVs in
several replication-competent hepatoma cells is mainly due to
disturbance in one or more of the early steps during viral entry.
The data and methods presented here may help to analyze and
overcome refractory cell lines by reconstitution of their respec-
tive defective entry steps and further pave the way toward the
establishment of permissive cell lines. Such convenient cell
lines or animal models are prerequisites for the development
of novel antiviral strategies that are apparently needed. It is
also obvious that drugs affecting viral binding, intracellular
trafficking, and nuclear import would be potent inhibitors of
viral infection. However, a more-complete understanding of
how hepadnaviruses exploit host factors for their entry in hepa-
tocytes is required to accomplish this aim.
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